Nuvectis Pharma (NVCT) Shares Issued (2021 - 2026)
Nuvectis Pharma (NVCT) posted Shares Issued of $348281.0 for Q1 2026, little changed sequentially from $348281.0 in Q4 2025, and up 4.5% YoY from $333281.0 in Q1 2025.
Nuvectis Pharma (NVCT) Shares Issued (2021 - 2026) Analysis & Trends
Nuvectis Pharma has reported Shares Issued for 6 years, with the latest figure at $348281.0 in Q1 2026.
- Quarterly Shares Issued rose 4.5% year-over-year to $348281.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $348281.0 (up 4.5% YoY) and the FY2025 annual result came in at $348281.0, changed 0.0% from the prior year.
- Shares Issued held at $348281.0 in Q1 2026 per NVCT's latest filing, from $348281.0 in the prior quarter.
- Over five years, Shares Issued peaked at $1.2 million in Q1 2024 and troughed at $21000.0 in Q2 2023.
- A 5-year average of $357568.4 and a median of $348281.0 in 2023 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2023 and 2024: Shares Issued sank 92.92% in 2023, then surged 1558.48% in 2024.
- Over 5 years, Shares Issued stood at $338807.0 in 2022, then grew by 2.8% to $348281.0 in 2023, then changed by 0.0% to $348281.0 in 2024, then changed by 0.0% to $348281.0 in 2025, then changed by 0.0% to $348281.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $348281.0, $348281.0, and $348281.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Nuvectis Pharma | 506.13 Mn | 506.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 348,281.00 |
| Mar 31, 2026 | 348,281.00 |
| Dec 31, 2025 | 348,281.00 |
| Dec 31, 2025 | 348,281.00 |
| Sep 30, 2025 | 348,281.00 |
| Sep 30, 2025 | 348,281.00 |
| Jun 30, 2025 | 348,281.00 |
| Jun 30, 2025 | 348,281.00 |
| Mar 31, 2025 | 333,281.00 |
| Mar 31, 2025 | 333,281.00 |
| Dec 31, 2024 | 348,281.00 |
| Dec 31, 2024 | 348,281.00 |
| Sep 30, 2024 | 348,281.00 |
| Sep 30, 2024 | 348,281.00 |
| Jun 30, 2024 | 348,281.00 |
| Jun 30, 2024 | 348,281.00 |
| Mar 31, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 348,281.00 |
| Dec 31, 2023 | 348,281.00 |